Objectives A few CLIA automated immunoassays for the recognition of anti S1-RBD SARS-
CoV-2 antibodies have recently been placed on the market. Preliminary data demonstrate a …

Background There is an urgent need for harmonization between severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) serology platforms and assays prior to defining …

Background and aims SARS-CoV-2 antibody assays are relevant in managing the COVID-
19 pandemic, providing valuable data on the immunization status of the population …

SARS-CoV-2 antibody tests are available in various formats, detecting different viral target
proteins and antibody subclasses. The specificity and sensitivity of SARS-CoV-2 antibody …

Background As serologic assays for SARS-CoV-2 become more widely utilized, it is
important to understand their performance characteristics and correlation with neutralizing …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December
2019 and caused a dramatic pandemic. Serological assays are used to check for …

Background: The introduction of the vaccination against SARS-CoV-2 infection creates the
need for precise tools for the quality control of vaccination procedures, detection of poor …

Objective In this study, the performance of 2 commercially available SARS-CoV-2 antibody
assays is evaluated. Methods The Siemens SARS-CoV-2 Total (COV2T) and IgG (COV2G) …

Background Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of …

Background In the context of the COVID-19 pandemic, numerous new serological test
systems for the detection of anti-SARS-CoV-2 antibodies rapidly have become available …